In Vivo Dynamics of Type 1 Fimbria Regulation in UropathogenicEscherichia coli during Experimental Urinary Tract Infection

ABSTRACT Escherichia coli is the primary cause of uncomplicated infections of the urinary tract including cystitis. More serious infections, characterized as acute pyelonephritis, can also develop. Type 1 fimbriae of E. coli contribute to virulence in the urinary tract; however, only recently has the expression of the type 1 fimbriae been investigated in vivo using molecular techniques. Transcription of type 1 fimbrial genes is controlled by a promoter that resides on a 314-bp invertible element capable of two orientations. One places the promoter in the ON orientation, allowing for transcription; the other places the promoter in the OFF orientation, preventing transcription. A PCR-based assay was developed to measure the orientation of the invertible element during an experimental urinary tract infection in mice. Using this assay, it was found that the percentage of the population ON in urine samples correlated with the respective CFU per gram of bladder (P = 0.0006) but not with CFU per gram of kidney (P > 0.069). Cystitis isolates present in the urine of mice during the course of infection had a higher percentage of their invertible elements in the ON orientation than did pyelonephritis isolates (85 and 34%, respectively, at 24 h; P < 0.0001). In general, cystitis isolates, unlike pyelonephritis isolates, were more likely to maintain their invertible elements in the ON orientation for the entire period of infection. E. coli cells expressing type 1 fimbriae, expelled in urine, were shown by scanning electron microscopy to be densely packed on the surface of uroepithelial cells. These results suggest that expression of type 1 fimbriae is more critical for cystitis strains than for pyelonephritis strains in the early stages of an infection during bladder colonization.

[1]  B. Uhlin,et al.  Regulatory cross‐talk between adhesin operons in Escherichia coli: inhibition of type 1 fimbriae expression by the PapB protein , 2000, The EMBO journal.

[2]  T. Chakraborty,et al.  Type 1 Fimbriation and Phase Switching in a NaturalEscherichia coli fimB Null Strain, Nissle 1917 , 1999, Journal of bacteriology.

[3]  Scott J. Hultgren,et al.  Bacterial Adhesins: Common Themes and Variations in Architecture and Assembly , 1999, Journal of bacteriology.

[4]  R. Russell,et al.  Comparison of Escherichia coli strains recovered from human cystitis and pyelonephritis infections in transurethrally challenged mice. , 1999, Infection and immunity.

[5]  H. Mobley,et al.  In vivo phase variation of Escherichia coli type 1 fimbrial genes in women with urinary tract infection. , 1999, Infection and immunity.

[6]  S. Hultgren,et al.  Induction and evasion of host defenses by type 1-piliated uropathogenic Escherichia coli. , 1998, Science.

[7]  H. Mobley,et al.  Genomic Analysis of a Pathogenicity Island in Uropathogenic Escherichia coli CFT073: Distribution of Homologous Sequences among Isolates from Patients with Pyelonephritis, Cystitis, and CatheterAssociated Bacteriuria and from Fecal Samples , 1998, Infection and Immunity.

[8]  D. Dykhuizen,et al.  Pathogenic adaptation of Escherichia coli by natural variation of the FimH adhesin. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[9]  D. Gally,et al.  Regulation of type 1 fimbrial expression in uropathogenic Escherichia coli : heterogeneity of expression through sequence changes in the fim switch region , 1998, Molecular microbiology.

[10]  J. Hacker,et al.  The Pai‐associated leuX specific tRNALeu5 affects type 1 fimbriation in pathogenic Escherichia coli by control of FimB recombinase expression , 1997, Molecular microbiology.

[11]  H. Mobley,et al.  Pathogenicity island sequences of pyelonephritogenic Escherichia coli CFT073 are associated with virulent uropathogenic strains , 1997, Infection and immunity.

[12]  S. Langermann,et al.  Prevention of mucosal Escherichia coli infection by FimH-adhesin-based systemic vaccination. , 1997, Science.

[13]  L. Truong,et al.  Development of experimental model of chronic pyelonephritis with Escherichia coli O75:K5:H-bearing Dr fimbriae: mutation in the dra region prevented tubulointerstitial nephritis. , 1997, The Journal of clinical investigation.

[14]  I. Blomfield,et al.  Integration host factor stimulates both FimB‐ and FimE‐mediated site‐specific DNA inversion that controls phase variation of type 1 fimbriae expression in Escherichia coli , 1997, Molecular microbiology.

[15]  C. Svanborg,et al.  Type 1 fimbrial expression enhances Escherichia coli virulence for the urinary tract. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[16]  I. Blomfield,et al.  Interaction of FimB and FimE with the fim switch that controls the phase variation of type 1 fimbriae in Escherichia coli K‐12 , 1996, Molecular microbiology.

[17]  H. Mobley,et al.  Urinary tract infections : molecular pathogenesis and clinical management , 1996 .

[18]  I. Blomfield,et al.  The leucine-responsive regulatory protein binds to the fim switch to control phase variation of type 1 fimbrial expression in Escherichia coli K-12 , 1994, Journal of bacteriology.

[19]  P. Klemm,et al.  Localization of promoters in the fim gene cluster and the effect of H-NS on the transcription of fimB and fimE. , 1994, FEMS microbiology letters.

[20]  A. Siitonen,et al.  Community-acquired pyelonephritis in adults: characteristics of E. coli isolates in bacteremic and non-bacteremic patients. , 1994, Scandinavian journal of infectious diseases.

[21]  C. Kunin,et al.  Urinary tract infections in females. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[22]  I. Blomfield,et al.  Environmental regulation of the fim switch controlling type 1 fimbrial phase variation in Escherichia coli K-12: effects of temperature and media , 1993, Journal of bacteriology.

[23]  M. S. McClain,et al.  Lrp stimulates phase variation of type 1 fimbriation in Escherichia coli K-12 , 1993, Journal of bacteriology.

[24]  A. Siitonen,et al.  Characteristics of Escherichia coli in acute community-acquired cystitis of adult women. , 1993, Scandinavian journal of infectious diseases.

[25]  M. S. McClain,et al.  Roles of fimB and fimE in site-specific DNA inversion associated with phase variation of type 1 fimbriae in Escherichia coli , 1991, Journal of bacteriology.

[26]  T. Kawula,et al.  Rapid site-specific DNA inversion in Escherichia coli mutants lacking the histonelike protein H-NS , 1991, Journal of bacteriology.

[27]  S. Moseley,et al.  Urovirulence determinants in Escherichia coli isolates causing first-episode and recurrent cystitis in women. , 1991, The Journal of infectious diseases.

[28]  K. Krogfelt,et al.  Direct evidence that the FimH protein is the mannose-specific adhesin of Escherichia coli type 1 fimbriae , 1990, Infection and immunity.

[29]  A. Schaeffer,et al.  In vivo expression and variation of Escherichia coli type 1 and P pili in the urine of adults with acute urinary tract infections , 1989, Infection and immunity.

[30]  R. Rubin,et al.  Molecular epidemiology of adhesin and hemolysin virulence factors among uropathogenic Escherichia coli , 1989, Infection and immunity.

[31]  E. Stokland,et al.  Virulence of Escherichia coli in relation to host factors in women with symptomatic urinary tract infection , 1988, Journal of clinical microbiology.

[32]  D. Friedman,et al.  Integration host factor is required for the DNA inversion that controls phase variation in Escherichia coli. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[33]  A. Schaeffer,et al.  Relationship of type 1 pilus expression in Escherichia coli to ascending urinary tract infections in mice , 1987, Infection and immunity.

[34]  L. Maurer,et al.  Receptor-binding function of type 1 pili effects bladder colonization by a clinical isolate of Escherichia coli , 1986, Infection and immunity.

[35]  P. Klemm,et al.  Two regulatory fim genes, fimB and fimE, control the phase variation of type 1 fimbriae in Escherichia coli. , 1986, The EMBO journal.

[36]  A. Schaeffer,et al.  Role of type 1 pili and effects of phase variation on lower urinary tract infections produced by Escherichia coli , 1985, Infection and immunity.

[37]  J. Abraham,et al.  An invertible element of DNA controls phase variation of type 1 fimbriae of Escherichia coli. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[38]  R. Haley,et al.  The nationwide nosocomial infection rate. A new need for vital statistics. , 1985, American journal of epidemiology.

[39]  R. Freter,et al.  Ascending, unobstructed urinary tract infection in mice caused by pyelonephritogenic Escherichia coli of human origin , 1983, Infection and immunity.

[40]  W. Anthony,et al.  A randomized, controlled trial of cefoperazone vs. cefamandole-tobramycin in the treatment of putative, severe infections with gram-negative bacilli. , 1983, Reviews of infectious diseases.